Oncology Research · Clinical Translation · Patient Access

Where oncology research
meets the people
who need it most.

KCLEAGENICS MEDICAL is an equal bridge between scientific discovery, clinical expertise and patient care — translating the latest oncology research into better outcomes for people living with cancer.

🔬
Foundation
Research
🩺
Delivery
Clinicians
🤝
Purpose
Patients
Scroll
Recognised by
GCP Certified
MHRA Compliant
ClinicalTrials.gov Registered
NHS Partner
Multidisciplinary Oncology Board
Our Three Pillars

Three equal commitments.
One unified purpose.

We don't serve research, clinicians, or patients in isolation. Our model is built on the conviction that all three are inseparable — and that progress in any one depends on excellence in all three.

01
🔬
Foundation
Oncology Research

We design and lead oncology clinical trials, contribute to peer-reviewed literature, and monitor global research to identify treatments ready for real-world translation.

Phase I–III trial design & management
Biomarker & genomic research programmes
Evidence synthesis & clinical literature review
Research ethics & regulatory compliance
View research portfolio →
02
🩺
Delivery
Clinical Partnership

We work alongside oncologists, haematologists and specialist nurses to integrate our research findings into clinical decision-making — and to facilitate patient referral into active trials.

Clinician education & research briefings
Patient referral & eligibility assessment
Multidisciplinary tumour board collaboration
Trial site partnership & investigator support
Refer a patient →
03
🤝
Purpose
Patient Access

Every study we conduct, every partnership we build, exists to expand access to better cancer care. We translate complex research into clear options, guidance and support for patients and their families.

Plain-language trial information & eligibility guides
Infusion therapy access & coordination
Patient navigator & carer support service
Post-trial follow-up & outcomes tracking
Your pathway →
Research Focus

Active programmes
shaping oncology care.

Our research agenda is shaped by unmet clinical need — focusing on areas where new evidence can meaningfully change patient outcomes today, not in a decade.

Join a Trial →
🩸
Haematological Malignancies
CLL, SLL, AML and lymphoma — exploring novel agents, drug combinations and supportive care strategies.
Recruiting
🧬
Precision & Genomic Oncology
Biomarker-driven trial design and molecular profiling to match patients with the therapies most likely to benefit them.
Recruiting
💊
Immuno-Oncology
Checkpoint inhibitors, CAR-T adjacent therapies and immunotherapy combination regimens across solid tumours.
In Development
⚖️
Cancer Risk & Metabolic Factors
Investigating the relationship between metabolic health, obesity-related risk, and cancer susceptibility across diverse populations.
Ongoing
How We Bridge

Discovery to bedside.
Without losing the human.

Our operating model is designed so that research insights flow to clinicians rapidly — and clinicians can give patients access to those insights with confidence and support.

🔬
Step 01 — Research
Evidence Generated
Our research team designs trials, monitors emerging literature, and synthesises findings into actionable clinical intelligence.
🩺
Step 02 — Translation
Clinicians Informed
We brief and support clinicians with research summaries, eligibility tools, and referral pathways — making adoption frictionless.
🤝
Step 03 — Access
Patients Reached
Patients and carers receive clear, plain-language information, coordinated access to trials, and ongoing support through treatment.
And patient outcomes feed directly back into our research — closing the loop.
Clinical Insights

Research translated
for clinicians and patients alike.

View all insights →
🧬 Precision Oncology
Closing the genomic testing gap: who gets access, and who doesn't
Molecular profiling is transforming cancer care — but equitable access remains deeply uneven. Our team examines what implementation really demands.
By Dr [Name], Oncology Director · July 2025
⚖️ Risk Factors · Prevention
Beyond BMI: why weight-related cancer risk needs an individual lens
A landmark trial highlights why population-level obesity metrics miss individual vulnerability — and how clinicians can respond.
By Dr [Name], Clinical Research · June 2025
Get Involved

Are you a patient, carer
or clinician?

Whether you're exploring trial options, looking to refer a patient, or interested in research collaboration — our team is the bridge you've been looking for.

📧 info@kcleagenicsmedical.com  ·  GCP Certified  ·  MHRA Compliant